Artwork

Content provided by UC San Diego Sanford Stem Cell Institute and Bobby Gordon. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Diego Sanford Stem Cell Institute and Bobby Gordon or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Dr. Catriona Jamieson | The Search for Cancer Cures in Outer Space

29:02
 
Share
 

Manage episode 490860726 series 3653900
Content provided by UC San Diego Sanford Stem Cell Institute and Bobby Gordon. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Diego Sanford Stem Cell Institute and Bobby Gordon or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This episode’s conversation focuses on the innovative work of Dr. Catriona Jamieson, Director of the Sanford Stem Cell Institute at UC San Diego, and the Axiom-4 (Ax-4) launch. This space research mission includes the Institute’s testing of the efficacy of “rebecsnib” on tumor organoids derived from cancer stem cells of consenting patients with secondary acute myeloid leukemia, ovarian cancer, metastatic breast cancer and glioblastoma multiforme. The drug holds potential to fight 23 types of cancer — any that involve ADAR1 in their development and progression. The hope is that the investigational new drug prevents the miniature tumors from growing, as it did on Axiom Space’s previous Ax-3 mission, with cell line-derived triple negative breast cancer tumor organoids. Hosted by Bobby Gordon This episode was recorded on June 6, 2025, and information presented is accurate as of this date.
  continue reading

8 episodes

Artwork
iconShare
 
Manage episode 490860726 series 3653900
Content provided by UC San Diego Sanford Stem Cell Institute and Bobby Gordon. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UC San Diego Sanford Stem Cell Institute and Bobby Gordon or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This episode’s conversation focuses on the innovative work of Dr. Catriona Jamieson, Director of the Sanford Stem Cell Institute at UC San Diego, and the Axiom-4 (Ax-4) launch. This space research mission includes the Institute’s testing of the efficacy of “rebecsnib” on tumor organoids derived from cancer stem cells of consenting patients with secondary acute myeloid leukemia, ovarian cancer, metastatic breast cancer and glioblastoma multiforme. The drug holds potential to fight 23 types of cancer — any that involve ADAR1 in their development and progression. The hope is that the investigational new drug prevents the miniature tumors from growing, as it did on Axiom Space’s previous Ax-3 mission, with cell line-derived triple negative breast cancer tumor organoids. Hosted by Bobby Gordon This episode was recorded on June 6, 2025, and information presented is accurate as of this date.
  continue reading

8 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play